4.6 Meeting Abstract

Early vedolizumab trough levels are not associated with a short-term response in patients with inflammatory bowel disease

Journal

JOURNAL OF CROHNS & COLITIS
Volume 13, Issue -, Pages S356-S356

Publisher

OXFORD UNIV PRESS

Keywords

-

Funding

  1. IBD-Comfort Foundation

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available